The (cost)-effectiveness of an early admission to and assessment in the nursing home for stroke patients

Completed

• Conditions: Circulatory System; Stroke, not specified as haemorrhage or infarction; Stroke

• Registration Number: ISRCTN58135104
• Lead Sponsor: VGZ Eindhoven (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01-04
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 222

Inclusion Criteria

1. Acute stroke patients' admitted to one of the hospitals participating in the trial
2. Aged 18 years or older
3. Either sex
4. Willingness to participate

Exclusion Criteria

1. A previous diagnosis of dementia
2. Unable to communicate in Dutch

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total direct and indirect costs per patient during the first 6 months post-stroke. <br><br>The economic evaluation will involve a combination of a cost-effectiveness analysis and a cost-utility analysis. The primary outcome measure of the cost-effectiveness analysis will be the Stroke-Adapted 30-Item Version of the Sickness Impact Profile (SASIP-30). Within the cost-utility analysis, outcomes will be measured by means of standard Dutch version of the Euroqol (EQ-5D). This is a self-administered questionnaire, which will be completed together with a cost questionnaire in which the resource utilisation is recorded. Measurements are taken at baseline and after 3 and 6 months post-stroke.